Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
Open Access
- 27 November 2017
- journal article
- Published by Springer Science and Business Media LLC in Molecular Systems Biology
- Vol. 13 (11), 955
- https://doi.org/10.15252/msb.20177697
Abstract
Cancer drug screening in patient-derived cells holds great promise for personalized oncology and drug discovery but lacks standardization. Whether cells are cultured as conventional monolayer or advanced, matrix-dependent organoid cultures influences drug effects and thereby drug selection and clinical success. To precisely compare drug profiles in differently cultured primary cells, we developed DeathPro, an automated microscopy-based assay to resolve drug-induced cell death and proliferation inhibition. Using DeathPro, we screened cells from ovarian cancer patients in monolayer or organoid culture with clinically relevant drugs. Drug-induced growth arrest and efficacy of cytostatic drugs differed between the two culture systems. Interestingly, drug effects in organoids were more diverse and had lower therapeutic potential. Genomic analysis revealed novel links between drug sensitivity and DNA repair deficiency in organoids that were undetectable in monolayers. Thus, our results highlight the dependency of cytostatic drugs and pharmacogenomic associations on culture systems, and guide culture selection for drug tests.Keywords
Funding Information
- Deutsches Krebsforschungszentrum (NCT3.0_2015.16 PDAC POP)
- Dietmar Hopp Stiftung
- Helmholtz-Gemeinschaft
- Deutsches Krebsforschungszentrum (HIPO 059)
This publication has 67 references indexed in Scilit:
- Emerging landscape of oncogenic signatures across human cancersNature Genetics, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancerBritish Journal of Cancer, 2012
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Dissecting the genomic complexity underlying medulloblastomaNature, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Micropilot: automation of fluorescence microscopy–based imaging for systems biologyNature Methods, 2011
- Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cellsLeukemia Research, 2008